SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-189000
Filing Date
2022-07-07
Accepted
2022-07-07 07:11:02
Documents
12
Period of Report
2022-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d537481d8k.htm   iXBRL 8-K 25338
  Complete submission text file 0001193125-22-189000.txt   147826

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20220707.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20220707_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20220707_pre.xml EX-101.PRE 11255
6 EXTRACTED XBRL INSTANCE DOCUMENT d537481d8k_htm.xml XML 3351
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 221070632
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences